Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococci

Journal of Biomedical Science

Volumn 23, Issue 1, 2016, Pages

  Mottola, Carla ^a   Semedo Lemsaddek, Teresa ^b   Mendes, João J ^c   Melo Cristino, José ^d   Tavares, Luís ^a   Cavaco Silva, Patrícia ^e,f   Oliveira, Manuela ^a  

^a FACULDADE DE MEDICINA VETERINÁRIA   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c HOSPITAL DE SANTA MARTA   (Portugal)

^d INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^e SA   (Portugal)

^f INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

Author keywords

CA MRSA; Diabetic foot staphylococci; HA MRSA; MLST; PFGE; Virulence factors

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; VIRULENCE FACTOR;

AGRI GENE; AGRII GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BAP GENE; BIOFILM; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; DIABETIC FOOT; DRUG TREATMENT FAILURE; GENETIC VARIABILITY; GENOTYPE; HUMAN; ICAA GENE; ICAD GENE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PORTUGAL; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; PVL GENE; SCREENING; STAPHYLOCOCCUS AUREUS; TST GENE; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PATHOGENICITY; QUANTITATIVE TRAIT;

DIABETIC FOOT; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; QUANTITATIVE TRAIT, HERITABLE; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 85008699035     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/s12929-016-0250-7     Document Type: Article

References (64)

1. Spichler A, Hurwitz BL, Armstrong DG, Lipsky BA. Microbiology of diabetic foot infections: from Louis Pasteur to "crime scene investigation. " BMC Med. 2015;13:1-13.
2. Rice JB, Desai U, Cummings AKG, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014;37:651-8.
3. Van Acker K, Léger P, Hartemann A, Chawla A, Kashif Siddiqui M: Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review. Diabetes Metab Res Rev 2014, 30:635-645.
4. Mendes JJ, Marques-Costa A, Vilela C, Neves J, Candeias N, Cavaco-Silva P, Melo-Cristino J. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract. 2012;95:153-61.
5. Zenelaj B, Bouvet C, Lipsky BA, Uckay I. Do Diabetic Foot Infections With Methicillin-Resistant Staphylococcus aureus Differ From Those With Other Pathogens? Int J Low Extrem Wounds. 2014;13:263-72.
6. Harastani HH, Araj GF, Tokajian ST. Molecular characteristics of Staphylococcus aureus isolated from a major hospital in Lebanon. Int J Infect Dis. 2014;19:33-8.
7. Sekhar S, Ohri M, Chakraborti A. Biofilms: an evolving and universal evasive strategy of bacterial pathogens. In: Mendez-Vilas A, editor. Current Research, Technology and Education Topics in Applied Microbiology and Microbial BioTechnology. Badajoz, Spain: Formatex; 2010. p. 855-859.
8. Cos P, Tote K. Biofilms: an extra hurdle for effective antimicrobial therapy. Curr Pharm Des. 2010;16:2279-95.
9. Potter A, Ceotto H, Giambiagi-Demarval M, dos Santos KRN, Nes IF, Bastos MDCDF. The gene bap, involved in biofilm production, is present in Staphylococcus spp. strains from nosocomial infections. J Microbiol. 2009;47:319-26.
10. Sifri CD. Healthcare epidemiology: quorum sensing: bacteria talk sense. Clin Infect Dis. 2008;47:1070-6.
11. Novick RP, Geisinger E. Quorum sensing in staphylococci. Annu Rev Genet. 2008;42:541-64.
12. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46 Suppl 5:S350-9.
13. Chambers HF, Deleo FR. Waves of Resistance: Staphylococcus aureus in the Antibiotic Era. Nat Rev Microbiol. 2010;7:629-41.
14. Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol. 2005;43:2384-90.
15. Durand G, Bes M, Meugnier H. New methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections. J Clin Microbiol. 2006;44:847-53.
16. Grundmann H, Schouls LM, Aanensen DM, Pluister GN, Tami A, Chlebowicz M, Glasner C, Sabat AJ, K W, O H, Friedrich AW: The dynamic changes of dominant clones of Staphylococcus aureus causing bloodstream infections in the European region: Results of a second structured survey. Euro Surveill 2014, 19(Suppl 49):1-10.
17. European Centre for Disease Prevention and Control (ECDC): Antimicrobial Resistance Surveillance in Europe 2012. 2012.
18. Aires de Sousa M, Conceicão T, Simas C, De Lencastre H. Comparison of Genetic Backgrounds of Methicillin-Resistant and -Susceptible Staphylococcus aureus Isolates from Portuguese Hospitals and the Community. J Clin Microbiol. 2005;43:5150-7.
19. Amorim ML, Vasconcelos C, Oliveira DC, Azevedo A, Calado E, Faria NA, Pereira M, Castro AP, Moreira A, Aires E, Cabeda JM, Ramos MH, Amorim JM, de Lencastre H. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization among patients and healthcare workers in a Portuguese hospital: a pre-intervention study toward the control of MRSA. Microb Drug Resist. 2009;15:19-26.
20. Tavares A, Faria NA, De Lencastre H, Miragaia M. Population structure of methicillin-susceptible Staphylococcus aureus (MSSA) in Portugal over a 19-year period (1992-2011). Eur J Clin Microbiol Infect Dis. 2014;33:423-32.
21. Almeida ST, Nunes S, Paulo ACS, Faria NA, de Lencastre H, Sá-Leão R. Prevalence, risk factors, and epidemiology of methicillin-resistant Staphylococcus aureus carried by adults over 60 years of age. Eur J Clin Microbiol Infect Dis. 2014;34:593-600.
22. Faria NA, Miragaia M, Lencastre, The Multi Laborat H. Massive Dissemination of Methicillin Resistant Staphylococcus aureus in Bloodstream Infections in a High MRSA Prevalence Country: Establishment and Diversification of EMRSA-15. Microb Drug Resist. 2013;19:483-90.
23. Pereira EM, Schuenck RP, Malvar KL, Iorio NLP, Matos PDM, Olendzki AN, Oelemann WMR, dos Santos KRN. Staphylococcus aureus, Staphylococcus epidermidis and Staphylococcus haemolyticus: methicillin-resistant isolates are detected directly in blood cultures by multiplex PCR. Microbiol Res. 2010;165:243-9.
24. Akineden Ö, Annemüller C, Hassan AA, Lämmler C, Zschöck M, Annemu C. Toxin genes and other characteristics of Staphylococcus aureus isolates from milk of cows with Mastitis. Society. 2001;8:959-64.
25. Arciola CR, Baldassarri L, Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheterassociated infections. J Clin Microbiol. 2001;39:2151-6.
26. Gilot P, Lina G, Cochard T, Poutrel B. Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from. J Clin Microbiol. 2002;40:4060-7.
27. Jarraud S, Mougel C, Thioulouse J. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002;70:631-41.
28. Clinical and Laboratory Standards Institute: M100-S23 Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. 2013.
29. Magiorakos A, Srinivasan A. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Eur J Clin Microbiol Infect Dis. 2012;18:268-81.
30. Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG. Multilocus Sequence Typing for characterization of Methicillin-Resistant and Methicillin-Susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008-15.
31. Ramakant P, Verma AK, Misra R, Prasad KN, Chand G, Mishra A, Agarwal G, Agarwal A, Mishra SK. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: Time for a rethink on which empirical therapy to choose? Diabetologia. 2011;54:58-64.
32. Shankar EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR. Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med. 2005;16:567-70.
33. Sekhar S, Vyas N, Unnikrishnan M, Rodrigues G, Mukhopadhyay C. Antimicrobial susceptibility pattern in diabetic foot ulcer: A pilot study. Ann Med Health Sci Res. 2014;4:742.
34. Tentolouris N, Petrikkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, Markou G, Katsilambros N. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect. 2006;12:186-9.
35. Sotto A, Lina G, Richard J. Virulence potential of Staphylococcus aureus strains isolated from diabetic foot ulcers. Diabetes Care. 2008;31:2318-24.
36. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care. 2006;29:1727-32.
37. Swarna SR, Madhavan R, Gomathi S, Thamaraiselvi S. A study of Biofilm on Diabetic Foot Ulcer. Int J Res Pharm Biomed Sci. 2012;3:1809-14.
38. Sader HS, Pritsche TR, Kaniga K, Ge Y, Jones RN. Antimicrobial activity and spectrum of PPI-0903 m (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains. Antimicrob Agents Chemother. 2005;49:3501-12.
39. Goldstein EJC, Citron DM, Merriam CV, Tyrrell KL. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds. Diagn Microbiol Infect Dis. 2013;76:347-51.
40. Lipsky BA. Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience. Diabetes Metab Res Rev. 2015;26:446-7.
41. Zhu W, Tenover FC, Limor J, Lonsway D, Prince D, Dunne WM, Patel JB. Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis. 2006;26:161-5.
42. Malik A, Mohammad Z, Ahmad J. The diabetic foot infections: biofilms and antimicrobial resistance. Diabetes Metab Syndr. 2013;7:101-7.
43. Citron DM, Goldstein EJC, Merriam CV, Lipsky BA, Abramson MA. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol. 2007;45:2819-128.
44. Melo-Cristino J, Resina C, Manuel V, Lito L, Ramirez M. First case of infection with vancomycin-resistant Staphylococcus aureus in Europe. Lancet. 2013;382:205.
45. Saravolatz LD, Pawlak J, Johnson LB. In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates. Clin Infect Dis. 2012;55:582-6.
46. Campion JJ, McNamara PJ, Evans ME. Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments. Antimicrob Agents Chemother. 2004;48:4733-44.
47. Martineau F, Picard FJ, Lansac N, Ménard C, Roy PH, Ouellette M, Bergeron MG. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 2000;44:231-8.
48. Zubair M, Malik A, Ahmad J, Rizvi M. A study of biofilm production by gram negative organisms isolated from diabetic foot ulcer patients. Biol Med. 2011;3:147-57.
49. Shakeri F, Shojai A, Golalipour M, Alang SR, Vaez H, Ghaemi EA. Spa diversity among MRSA and MSSA strains of Staphylococcus aureus in north of Iran. Int J Microbiol. 2010;2010:12-7.
50. Mottola C, Mendes JJ, Cristino JM, Cavaco-Silva P, Tavares L, Oliveira M: Polymicrobial biofilms by diabetic foot clinical isolates. Folia Microbiol (Praha) 2015, 61(Suppl 1):35-43.
51. Hartford O, O'Brien L, Schofield K, Wells J, Foster T. The Fbe (SdrG) protein of Staphylococcus epidermidis adherance to fibrinogen. Microbiology. 2001;147:2545-1452.
52. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J. Communityacquired methicillin-resistant Staphylococcus aureus carrying pantonvalentine leukocidin genes: Worldwide emergence. Emerg Infect Dis. 2003;9:978-84.
53. Nazareth R, Gonçalves-Pereira J, Tavares A, Miragaia M, de Lencastre H, Silvestre J, Freitas P, Gonçalves E, Martins F, Mendes V, Tapadinhas C, Póvoa P. Infeção por staphylococcus aureus meticilina-resistente da comunidade em Portugal. Rev Port Pneumol. 2012;18:34-8.
54. Francois P, Koessler T, Huyghe A, Harbarth S, Bento M, Lew D, Pittet D, Schrenzel J: Rapid Staphylococcus aureus agr type determination by a novel Multiplex Real-Time Quantitative PCR assay. J Clin Microbiol 2006.
55. Machuca MA, Sosa LM, González CI. Molecular typing and virulence characteristic of methicillin-resistant Staphylococcus aureus isolates from pediatric patients in Bucaramanga, Colombia. PLoS One. 2013;8:e73434.
56. Traber KE, Lee E, Benson S, Corrigan R, Cantera M, Shopsin B, Novick RP. agr function in clinical Staphylococcus aureus isolates. Microbiology. 2008;154(Pt 8):2265-74.
57. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
58. Monecke S, Coombs G, Shore AC, Coleman DC, Akpaka P, Borg M, Chow H, Ip M, Jatzwauk L, Jonas D, Kadlec K, Kearns A, Laurent F, O'Brien FG, Pearson J, Ruppelt A, Schwarz S, Scicluna E, Slickers P, Tan HL, Weber S, Ehricht R. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One. 2011;6:e17936.
59. Aires-de-Sousa M, Correia B, De Lencastre H, Alves V, Branca F, Cabral L, Clemente J, Daniel I, Faustino A, Ferreira E, Lameiras C, Lopes J, Marques J, Peres I, Ribeiro G, Sancho L, Santos O, Santos P, Vaz MT, Videira Z. Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in Portuguese hospitals: Surveillance over a 16-year period. J Clin Microbiol. 2008;46:2912-7.
60. Monecke S, Ehricht R. Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays. Clin Microbiol Infect. 2005;11:825-33.
61. Tavares A, Miragaia M, Rolo J, Coelho C, De Lencastre H. High prevalence of hospital-associated methicillin-resistant Staphylococcus aureus in the community in Portugal: Evidence for the blurring of community-hospital boundaries. Eur J Clin Microbiol Infect Dis. 2013;32:1269-83.
62. Espadinha D, Faria NA, Miragaia M, Lito LM, Melo-Cristino J, de Lencastre H, Network MS. Extensive dissemination of Methicillin-Resistant Staphylococcus aureus (MRSA) between the hospital and the community in a country with a high prevalence of nosocomial MRSA. PLoS One. 2013;8:1-8.
63. Sakwinska O, Kuhn G, Balmelli C, Francioli P, Giddey M, Perreten V, Riesen A, Zysset F, Blanc DS, Moreillon P. Genetic diversity and ecological success of staphylococcus aureus strains colonizing humans. Appl Environ Microbiol. 2009;75:175-83.
64. Fan J, Shu M, Zhang G, Zhou W, Jiang Y, Zhu Y, Chen G, Peacock SJ, Wan C, Pan W, Feil EJ. Biogeography and virulence of Staphylococcus aureus. PLoS One. 2009;4:e6216.